HOME >> BIOLOGY >> NEWS
PSA Levels Mean More Extensive Prostate Disease In Older Men

In a study of prostate cancer at different ages, Johns Hopkins researchers have found that at diagnosis, older men have more extensive disease than younger men even if their prostate specific antigen (PSA) levels are the same. PSA is a protein made by the prostate; rising blood levels suggest that the prostate is enlarged or even cancerous.

"The finding shows that both doctors and older men must be especially vigilant," says H. Ballentine Carter, M.D., associate professor of urology. "The blood test results don't necessarily mean the same level of disease when ages differ," he said. The study, presented May 31 at the annual meeting of the American Urological Association in San Diego, Calif., was done with cancers that could not be detected by digital rectal exams.

The results are a new wrinkle on a long-standing problem over deciding whether to do further testing on men with raised PSA levels, Carter says. "Lowering the PSA threshold means you pick up more small, harmless tumors. Raising the PSA threshold means you're more likely to miss life-threatening tumors. The present study gives us age as an additional guide in deciding when it might be worthwhile to do further testing in men with non-palpable prostate cancer. At any particular PSA level, a key factor in catching cancer when it is still curable is the man's age." The Hopkins team studied 492 men who had undergone surgery to remove their prostates. The men were divided into three age groups (40-50, n=69; 51-60, n=227; 61-73, n=196) and five pre-treatment PSA categories: (2.5-4.0, n=36; 4.1-6.0, n=100; 6.1-8.0, n=122; 8.1-10.0, n=76; >10.0, n=135). Patients were considered curable if the cancer was either confined to the prostate or had not spread outside the gland to lymph nodes and the seminal vesicles.

For a given PSA range, increasing age was associated with lower probability of cure. If a man 40 to 50 years old had a PSA level of 4.0, for example, he had an 89 percent chance of havi
'"/>

Contact: Marc Kusinitz
mkusinit@welchlink.welch.jhu.edu
(410)955-8665
Johns Hopkins Medical Institutions
31-May-1998


Page: 1 2

Related biology news :

1. The Reason The French Have Low Levels Of Heart Disease
2. Marine Life In South Pacific Region Found To Be Impervious To Oceans Highest Arsenic Levels
3. Breast Milk Of Women Who Eat Lake Ontario Fish Contains High Levels Of PCBs, UB Study Finds
4. For First Time In 40 Years National Jewish Researchers Report Chronic Beryllium Disease Caused By Extremely Low Levels Of Exposure
5. Residential Dust Control Fails To Reduce Blood Lead Levels In Children
6. New Hampshire Study Shows Well Water Has Higher Arsenic Levels Than Municipal Water
7. Higher Levels Of Protein May Predict Heart Disease
8. Elevated Blood Levels Of Inactive TPA Linked To Increased Stroke Risk In Young Women
9. Alcohol Consumption, Resistance To Its Effects Related To Levels Of Neurotransmitter, Say UW Researchers
10. USC Scientists Find That Multi-Vitamin Use And Hormone Replacement Therapy MayLower Levels Of Homocysteine
11. Stress Hormone Levels Predict Length Of Gestation In Human Pregnancy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/11/2018)... ... October 11, 2018 , ... ODSC Europe 2018 - one of ... attendance at the event from September 19-22. , As Europe’s largest applied data ... 10 tracks and 4 days. Attendees were given key insights and hands-on training ...
(Date:10/11/2018)... ... October 11, 2018 , ... Better lives through a healthy ... Innovation in Manufacturing Biopharmaceuticals (NIIMBL). The Institute, a public-private partnership launched in March ... workforce development in the United States. Biopharmaceuticals are important because they treat and ...
(Date:10/5/2018)... ... October 04, 2018 , ... CallTower Inc., ... was present at Microsoft Ignite 2018, in Orlando, Florida, when Microsoft made a ... a statement about the new direction of Skype for Business Online, outlining the ...
Breaking Biology News(10 mins):
(Date:9/28/2018)... , ... September 28, 2018 , ... ... (PMLS) to increase the availability of the GlycoMark test, the only FDA-cleared blood ... With the partnership, PMLS will promote and offer the GlycoMark test to its ...
(Date:9/27/2018)... ... 26, 2018 , ... NDA Partners Chairman Carl Peck, ... and in vitro diagnostic device expert with more than 28 years of experience ... as an Expert Consultant. Her experience includes leadership roles in regulatory strategy, quality ...
(Date:9/27/2018)... BOSTON (PRWEB) , ... September 26, 2018 , ... ... conference. Medable is a platform that aims to build the first human digitome, ... clinical trial and real-world data through a seamless integration of all data sources. ...
(Date:9/27/2018)... (PRWEB) , ... September 27, 2018 , ... ... York City, Everwell Health Solutions and SureAdhere Mobile Technology, Inc. announced they will ... medication monitoring in the battle against tuberculosis (TB) and other diseases. These two ...
Breaking Biology Technology:
Cached News: